Risk Management on the PRMS Blog

Are you are thinking about adding e-prescribing to your practice? Or do you practice in New York (where you must begin e-prescribing by March 27th) and don’t know where to start? Here’s what you need to know: 1. Understand the law – federal and state Most federal law relevant to e-prescribing involves electronic prescribing of controlled substances (EPCS). The software vendor m ...

Can’t decide what resolutions to make for 2015? How about making a resolution to improve patient care and reduce liability? We know from our experience in handling more than 20,000 claims and lawsuits against psychiatrists that your highest risk exposures are related to psychopharmacology and treating patients with suicidal behaviors. We also know that there are specific steps ...

I’ve recently had several calls from physicians who have developed an online presence to seek new patients. Online marketing of your practice seems like a great option to grow a practice. However, what I’m hearing is that many patients who find doctors online do not want a treatment relationship, but rather only want controlled substances. To dissuade potential patients who sim ...

Here are my top four things to consider before using Skype – or any other technology – for telemedicine: 1) Does the technology comply with HIPAA’s requirements? Under the Privacy Rule, the technology vendor is a Business Associate if it stores (for any amount of time, no matter how short) or has access to protected health information (patient demographic and medical informatio ...

As I am finalizing preparation for PRMS’ national CME seminar on technology in San Francisco on October 18, I saw the headlines about the hospital EHR flaw that is being mentioned in the press as a reason for the Ebola patient’s initial release from the hospital and the resulting public harm threat. From CNBC: “’The hospital Thursday night said when Duncan was first examined Se ...

If you’ve paid attention to the news lately, you’ve more than likely seen headlines about Johnson & Johnson being involved in litigation related to the marketing of Risperdal.  Recently, our clients have begun to receive more requests for medical records in connection with Risperdal litigation. In the event that you receive any such request, we would like to remind you to k ...

The Wall Street Journal and The New York Times reported on an article in today’s issue of The Lancet entitled “Identification of risk loci with shared effects on five psychiatric disorders: a genome-wide analysis”  (free, but registration required).  The article suggests that there is an apparent genetic relationship involving calcium-channel activity genes among the five major ...

There has been a flurry of news affecting psychiatrists recently, including, but not limited to: – President Obama’s list “Gun Violence Reduction Executive Actions” which includes, among 21 others, these actions: – “Clarify that the Affordable Care Act does not prohibit doctors from asking their patients about guns in their homes.” – “Release a letter to health care providers c ...

Right after Labor Day each year, “meeting season” starts. From early September through mid-November, it seems every psychiatric organization holds a meeting; our goal is to attend as many of them as possible. In the past nine weeks, PRMS staff attended more than 50 meetings throughout the country.  These included APA district branch meetings, US Psychiatric Congress, Northern C ...

We compiled three documents related to child and adolescent psychiatry to distribute to our customers at the AACAP meeting in San Francisco: (1) a resource list of articles and websites on Youth Violence and Homicidal and Suicidal Behavior; (2) a list of the top 50 professional liability points for child and adolescent psychiatrists, and (3) a collection of our own risk managem ...